REQUEST A DEMO
Total
USD $0.00
Search more companies

Farma Pet Gigi SIA (Latvia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Farma Pet Gigi SIA Profile Updated: July 24, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Russian Download a sample report

Farma Pet Gigi SIA is a company in Latvia, with a head office in Riga. The enterprise operates in the Pharmaceutical Preparation Manufacturing industry. It was incorporated on February 19, 2013. 12 (2023) employees currently work for Farma Pet Gigi SIA. In its most recent financial highlights, the company reported a net sales revenue increase of 51.24% in 2025. Its total assets decreased by 17.63% over the same period. In 2025, Farma Pet Gigi SIA’s net profit margin increased by 125.11%.

Headquarters
Matisa iela 86 k-1
Riga; Riga; Postal Code: 1009

Contact Details: Purchase the Farma Pet Gigi SIA report to view the information.

Basic Information
Total Employees:
Purchase the Farma Pet Gigi SIA report to view the information.
Registered Capital:
Purchase the Farma Pet Gigi SIA report to view the information.
Financial Auditors:
Purchase the Farma Pet Gigi SIA report to view the information.
Incorporation Date:
February 19, 2013
Key Executives
Purchase this report to view the information.
Member of Management Board
Purchase this report to view the information.
Member of Management Board
Purchase this report to view the information.
Member of Management Board
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Farma Pet Gigi SIA report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
51.24%
Total Operating Revenue
49.95%
Operating Profit
45.62%
Net Profit/Loss for the Period
44.47%
Total Assets
-17.63%
Total Equity
-43.18%
Operating Profit Margin
120.89%
Net Profit Margin
125.11%
Return on Equity (ROE)
1.77%
Quick Ratio
-0.98%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?